Literature DB >> 14663119

Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin.

R F Nieuwenhuis1, J M Ossewaarde, W I van der Meijden, H A M Neumann.   

Abstract

The incidence of lymphogranuloma venereum (LGV) is low in the western world. Early LGV is characterised by bubonic disease following a painless papule or small ulcer. We report a white bisexual male who presented with a painful perianal ulcer, inguinal lymphadenitis, and concomitant infection with human immunodeficiency virus 1 (HIV-1). Chlamydia trachomatis serovar L2 was identified as the cause after polymerase chain reaction and genotyping the major outer membrane protein by restricted fragment length polymorphism. Treatment with a single dose of 1 g azithromycin was effective. This case illustrates that early LGV may mimic other genital ulcer diseases, such as genital herpes or chancroid, especially in HIV infected patients. In the western world, LGV must still be included in the differential diagnosis of bubonic disease with or without sexually acquired ulcers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663119      PMCID: PMC1744771          DOI: 10.1136/sti.79.6.453

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  14 in total

Review 1.  Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries.

Authors:  R Martin-Iguacel; J M Llibre; H Nielsen; E Heras; L Matas; R Lugo; B Clotet; G Sirera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-28       Impact factor: 3.267

2.  Pressure ulcer-like presacral gummata in a patient with tertiary syphilis.

Authors:  Uwe Wollina; André Koch; Mohammed Badawy Abdel-Naser; Jacqueline Schönlebe
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

3.  Update on lymphogranuloma venereum in the United Kingdom.

Authors:  Heather Jebbari; Sarah Alexander; Helen Ward; Barry Evans; Maria Solomou; Alicia Thornton; Gillian Dean; John White; Patrick French; Catherine Ison
Journal:  Sex Transm Infect       Date:  2007-06-25       Impact factor: 3.519

Review 4.  Sexually transmitted infections: where are we now?

Authors:  C Robertson; A Jayasuriya; P S Allan
Journal:  J R Soc Med       Date:  2007-09       Impact factor: 5.344

5.  Absence of lymphogranuloma venereum infection among high-risk men who have sex with men in Lima, Peru.

Authors:  Jesse L Clark; Benjamin Espinosa; Segundo R Leon; Eric R Hall; Hector J Salvatierra; Carlos F Cáceres; Jeffrey D Klausner; Thomas J Coates
Journal:  Int J STD AIDS       Date:  2008-06       Impact factor: 1.359

Review 6.  [Lymphogranuloma venereum. Two cases from Dresden].

Authors:  P Spornraft-Ragaller; C Lück; E Straube; M Meurer
Journal:  Hautarzt       Date:  2006-12       Impact factor: 0.751

7.  Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.

Authors:  Hencelyn Chu; Anatoly Slepenkin; Mikael Elofsson; Pia Keyser; Luis M de la Maza; Ellena M Peterson
Journal:  Int J Antimicrob Agents       Date:  2010-06-01       Impact factor: 5.283

8.  Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates.

Authors:  Nicholas R Thomson; Matthew T G Holden; Caroline Carder; Nicola Lennard; Sarah J Lockey; Pete Marsh; Paul Skipp; C David O'Connor; Ian Goodhead; Halina Norbertzcak; Barbara Harris; Doug Ormond; Richard Rance; Michael A Quail; Julian Parkhill; Richard S Stephens; Ian N Clarke
Journal:  Genome Res       Date:  2007-11-21       Impact factor: 9.043

9.  New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam.

Authors:  Joke Spaargaren; Han S A Fennema; Servaas A Morré; Henry J C de Vries; Roel A Coutinho
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

10.  Chlamydia and male lower urinary tract diseases.

Authors:  Young-Suk Lee; Kyu-Sung Lee
Journal:  Korean J Urol       Date:  2013-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.